Walter Cromer1, Wei Wang, Scott D Zawieja, Pierre-Yves von der Weid, M Karen Newell-Rogers, David C Zawieja. 1. *Division of Lymphatic Biology, Department of Medical Physiology, Texas A&M University Health Science Center College of Medicine, Temple, Texas; †Department of Physiology and Pharmacology, Inflammation Research Network, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB, Canada; and ‡Department of Surgery, Center for Cell Death and Differentiation, Texas A&M University Health Science Center College of Medicine, Temple, Texas.
Abstract
BACKGROUND: Lymphatic dysfunction has been linked to inflammation since the 1930s. Lymphatic function in the gut and mesentery is grossly underexplored in models of inflammatory bowel disease despite the use of lymphatic occlusion in early models of inflammatory bowel disease. Activation of the innate and adaptive immune system is a hallmark of TNBS-induced inflammation and is linked to disruption of the intrinsic lymph pump. Recent identification of crosstalk between lymphatic vessel resident immune cells and regulation of lymphatic vessel contractility underscore the importance of the timing of lymphatic dysfunction during tissue inflammation in response to TNBS. METHODS: To evaluate lymphatic function in TNBS induced inflammation, lymph was collected and flow measured from mesenteric lymphatics. Cellularity and cytokine profile of the lymph was also measured. Histopathology was performed to determine severity of injury and immunofluorescent staining of the mesentery was done to evaluate changes in the population of immune cells that reside near and on gastro-intestinal collecting lymphatics. RESULTS: Lymph transport fell 24 hours after TNBS administration and began recovering at 72 hours. Significant reduction of lymph flow preceded significant increase in histopathological score and occurred simultaneously with increased myeloperoxidase activity. These changes were preceded by increased MHCII cells surrounding mesenteric lymphatics leading to an altered lymphatic environment that would favor dysfunction. CONCLUSIONS: Alterations in environmental factors that effect lymphatic function occur before the development of gross GI inflammation. Reduced lymphatic function in TNBS-mediated inflammation is likely an early factor in the development of injury and that recovery of function is associated with resolution of inflammation.
BACKGROUND:Lymphatic dysfunction has been linked to inflammation since the 1930s. Lymphatic function in the gut and mesentery is grossly underexplored in models of inflammatory bowel disease despite the use of lymphatic occlusion in early models of inflammatory bowel disease. Activation of the innate and adaptive immune system is a hallmark of TNBS-induced inflammation and is linked to disruption of the intrinsic lymph pump. Recent identification of crosstalk between lymphatic vessel resident immune cells and regulation of lymphatic vessel contractility underscore the importance of the timing of lymphatic dysfunction during tissue inflammation in response to TNBS. METHODS: To evaluate lymphatic function in TNBS induced inflammation, lymph was collected and flow measured from mesenteric lymphatics. Cellularity and cytokine profile of the lymph was also measured. Histopathology was performed to determine severity of injury and immunofluorescent staining of the mesentery was done to evaluate changes in the population of immune cells that reside near and on gastro-intestinal collecting lymphatics. RESULTS: Lymph transport fell 24 hours after TNBS administration and began recovering at 72 hours. Significant reduction of lymph flow preceded significant increase in histopathological score and occurred simultaneously with increased myeloperoxidase activity. These changes were preceded by increased MHCII cells surrounding mesenteric lymphatics leading to an altered lymphatic environment that would favor dysfunction. CONCLUSIONS: Alterations in environmental factors that effect lymphatic function occur before the development of gross GI inflammation. Reduced lymphatic function in TNBS-mediated inflammation is likely an early factor in the development of injury and that recovery of function is associated with resolution of inflammation.
Authors: Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell Journal: Nat Biotechnol Date: 2007-09-16 Impact factor: 54.908
Authors: Scott D Zawieja; Jorge A Castorena-Gonzalez; Joshua P Scallan; Michael J Davis Journal: Am J Physiol Heart Circ Physiol Date: 2018-01-05 Impact factor: 4.733
Authors: Echoe M Bouta; Richard D Bell; Homaira Rahimi; Lianping Xing; Ronald W Wood; Clifton O Bingham; Christopher T Ritchlin; Edward M Schwarz Journal: Nat Rev Rheumatol Date: 2018-01-11 Impact factor: 20.543
Authors: Walter E Cromer; Scott D Zawieja; Karen M Doersch; Hayden Stagg; Felicia Hunter; Binu Tharakan; Ed Childs; David C Zawieja Journal: Lymphat Res Biol Date: 2018-01-23 Impact factor: 2.589
Authors: Yingxuan Chen; Sonia Rehal; Simon Roizes; Hai-Lei Zhu; William C Cole; Pierre-Yves von der Weid Journal: Microcirculation Date: 2017-04 Impact factor: 2.628
Authors: Audrey Seamons; Piper M Treuting; Stacey Meeker; Charlie Hsu; Jisun Paik; Thea Brabb; Sabine S Escobar; Jonathan S Alexander; Aaron C Ericsson; Jason G Smith; Lillian Maggio-Price Journal: Am J Pathol Date: 2018-05-18 Impact factor: 4.307
Authors: Sanjukta Chakraborty; Scott D Zawieja; Wei Wang; Yang Lee; Yuan J Wang; Pierre-Yves von der Weid; David C Zawieja; Mariappan Muthuchamy Journal: Am J Physiol Heart Circ Physiol Date: 2015-10-09 Impact factor: 4.733
Authors: M Al-Kofahi; F Becker; F N E Gavins; M D Woolard; I Tsunoda; Y Wang; D Ostanin; D C Zawieja; M Muthuchamy; P Y von der Weid; J S Alexander Journal: Br J Pharmacol Date: 2015-07-06 Impact factor: 8.739